R&D News | pharmaphorum

News

Bayer aims Mirena at women's health issue with no treatment

Bayer has started a phase 3 trial of its Mirena contraceptive in an endometrial disorder, with no treatments, that can lead to cancer.

News

Man and woman AI heads - representation concept

FDA doubles down on its push into AI

The FDA has revealed the latest element in its adoption of AI, an agentic AI platform that agency staffers can use to streamline complex tasks.

News

Female HCP talks to female patient sat on examination table

Slow recruitment still hitting UK trials, says pharma

Despite efforts to improve the environment for UK clinical trials, the sector is still facing headwinds like low recruitment rates and rising costs.

News

Belite plans filing for oral Stargardt drug after phase 3 wi...

The first therapy for sight-robbing Stargardt disease could be on the way, as Belite Bio's tinlarebant hits the mark in a phase 3 trial.

News

Real-world trial of Lilly's tirzepatide starts in UK

A real-world study exploring the long-term effects of Eli Lilly's weight-loss therapy tirzepatide in primary care settings has started in the UK.

News

Is FDA about to restrict vaccination even further?

Vinay Prasad, head of CBER, is reported to be planning to tighten regulations on vaccines after concluding that COVID-19 shots caused 10 child deaths.

Bayer aims Mirena at women's health issue with no treatment

FDA doubles down on its push into AI

Slow recruitment still hitting UK trials, says pharma

Belite plans filing for oral Stargardt drug after phase 3 wi...

Real-world trial of Lilly's tirzepatide starts in UK

Is FDA about to restrict vaccination even further?

AI, start-ups, and the future of human health: AION Labs’ Ma...

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks